ProShares UltraPro Short NASDAQ Biotechnology logo

ProShares UltraPro Short NASDAQ Biotechnology Income Statement

Revenue, expenses, and profitability over time
Market Cap$1.0B

No metrics found for this filter.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.